.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
US Department of Justice
Baxter
Daiichi Sankyo
McKesson
UBS
Covington
Fish and Richardson
Accenture
Cipla

Generated: December 15, 2017

DrugPatentWatch Database Preview

NALLPEN Drug Profile

« Back to Dashboard

Which patents cover Nallpen, and what generic alternatives are available?

Nallpen is a drug marketed by Glaxosmithkline and Baxter Hlthcare and is included in three NDAs.

The generic ingredient in NALLPEN is nafcillin sodium. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
Drug patent expirations by year for NALLPEN

Medical Subject Heading (MeSH) Categories for NALLPEN

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
GlaxosmithklineNALLPENnafcillin sodiumINJECTABLE;INJECTION061999-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Baxter HlthcareNALLPEN IN PLASTIC CONTAINERnafcillin sodiumINJECTABLE;INJECTION050655-002Oct 31, 1989RXYesYes► Subscribe► Subscribe► Subscribe
GlaxosmithklineNALLPENnafcillin sodiumINJECTABLE;INJECTION062755-002Dec 19, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Baxter HlthcareNALLPEN IN PLASTIC CONTAINERnafcillin sodiumINJECTABLE;INJECTION050655-001Oct 31, 1989RXYesYes► Subscribe► Subscribe► Subscribe
GlaxosmithklineNALLPENnafcillin sodiumINJECTABLE;INJECTION062755-001Dec 19, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineNALLPENnafcillin sodiumINJECTABLE;INJECTION061999-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineNALLPENnafcillin sodiumINJECTABLE;INJECTION061999-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
GlaxosmithklineNALLPENnafcillin sodiumINJECTABLE;INJECTION061999-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Teva
Chubb
US Department of Justice
McKinsey
UBS
Cantor Fitzgerald
McKesson
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot